SLC2A14

Across TCGA pan-cancer cohorts, SLC2A14 RNA differs between tumor and matched normal tissue in 8 of 18 cancer types tested, making tumor–normal expression one of SLC2A14’s most consistent transcriptional readouts.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where SLC2A14 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types SLC2A14 is over-expressed in tumor, although a few such as KICH and COAD show the opposite, repressed pattern.

KIRC, HNSC, and LUAD are the cancer types where SLC2A14 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in SLC2A14 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
KIRC	Male	All	+0.335	<.001	9	view →
HNSC	Male	II,III,IV	+0.138	<.001	8	view →
LUAD	All	All	+0.201	.002	7	view →
KIRP	All	All	+0.271	<.001	6	view →
KICH	All	All	−0.062	<.001	6	view →
LIHC	All	II,III,IV	+0.189	.010	5	view →
LUSC	Female	All	+0.549	.045	1	view →
COAD	Female	IV	−0.210	.027	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 8 strongest of 8 lineages.

SLC2A14–KIRC

Open the KIRC breakdown →